Chymotrypsin attenuates adjuvant-induced arthritis by downregu!ating TLR4, NF-κB, MMP-1, TNF-α, IL-1β, and IL-6 expression in Sprague-Dawley rats

被引:7
作者
Li, Jianqiang [1 ,2 ]
Wang, Linlin [1 ,2 ]
Zeng, Guangting [3 ]
Li, Huilan [1 ,2 ]
Luo, Jia [1 ,2 ]
Tian, Qijun [4 ]
Zhang, Zanling [1 ,2 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Inst Rational & Safe Med Practices, Changsha, Peoples R China
[3] Xiangnan Univ, Peoples Hosp Chenzhou 1, Dept Pharm, Chenzhou, Peoples R China
[4] Jianqiao Pharmaceut Ltd Liabil Co Hunan Prov, Changsha, Peoples R China
关键词
Chymotrypsin; rheumatoid arthritis; TLR4/NF-kappa B signaling pathway; MMP-1; TNF-alpha; IL-1; beta; IL-6; MATRIX METALLOPROTEINASES; PROTEOLYTIC-ENZYMES; PROTEIN; INFLAMMATION; ANTAGONIST; PATHWAYS; THERAPY;
D O I
10.1080/08923973.2022.2093743
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: Rheumatoid arthritis (RA) is mainly characterized by synovial hyperplasia, angiogenesis, inflammatory cells infiltration. Chymotrypsin is a proteolytic enzyme with anti-inflammatory effects. The current project was intended to test the efficacy and mechanism of chymotrypsin in adjuvant-induced arthritis (AIA) rats to provide an experimental basis for the clinical application of chymotrypsin. Methods: Sprague-Dawley rats were injected with complete Freund's adjuvant (CFA) in the hind left paw pad to establish an AIA model. Forty rats were randomly divided into five groups (n = 8): blank; CFA model (model); low-dose chymotrypsin (CLD), 0.53 mg/kg; high-dose chymotrypsin (CHD), 1.06 mg/kg; piroxicam, 10 mg/kg. The treatments were performed in the subplantar region of the left hind paw from Day 8 (D8) to Day 28 after adjuvant injection. The body weight, paw diameter, swelling degree of paw, and arthritic score were measured on D0, D7, D14, D21, and D28. All animals were sacrificed on D29. Subsequently, the synovial tissue of the ankle joint of the rats was stained with HE to generate pathological sections for observation of the pathological changes of synovial tissue from the ankle joint. The protein levels of MMP-1, TNF-alpha, IL-1 beta, and IL-6 in the rats' serum were determined by ELISA. Western blotting was used to detect the protein expression of TLR4 and NF-kappa B in the rat ankle tissue. The mRNA expression of TLR4, NF-kappa B, IL-1 beta, IL-6, and TNF-alpha in synovial tissue of the ankle joint was detected by RT-qPCR. Results: The body weight of the rats in each group showed an increasing trend, and there was no significant difference in weight between the groups. CHD and piroxicam suppressed paw swelling and arthritic scores and decreased synovial hyperplasia, inflammatory cell infiltration, pannus formation, and bone destruction. Furthermore, the overproduction of MMP-1, TNF-alpha, IL-1 beta, and IL-6 in serum was remarkably attenuated in the chymotrypsin- and piroxicam-treated rats. The protein levels of TLR4 and NF-kappa B in the synovial tissue of the chymotrypsin group and the piroxicam group were significantly lower than those in the model group. Likewise, the rats treated with chymotrypsin and piroxicam had a substantial decline in the mRNA expression of TLR4, NF-kappa B, TNF-alpha, IL-1 beta, and IL-6 in synovial tissue. Conclusions: Chymotrypsin alleviates the joint damage of AIA rats, probably by reducing the expression of MMP-1, TNF-alpha, IL-1 beta, and IL-6 through TLR4/NF-kappa B signaling pathway.
引用
收藏
页码:959 / 969
页数:11
相关论文
共 47 条
[1]   Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis [J].
Abdollahi-Roodsaz, Shahla ;
Joosten, Leo A. B. ;
Koenders, Marije I. ;
Devesa, Isabel ;
Roelofs, Mieke F. ;
Radstake, Timothy R. D. J. ;
Heuvelmans-Jacobs, Marleen ;
Akira, Shizuo ;
Nicklin, Martin J. H. ;
Ribeiro-Dias, Fatima ;
Van den Berg, Wim B. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (01) :205-216
[2]  
[Anonymous], 2015, MEDIAT INFLAMM, DOI DOI 10.1155/2015/194864
[3]   Matrix Metalloproteinase Gene Activation Resulting from Disordred Epigenetic Mechanisms in Rheumatoid Arthritis [J].
Araki, Yasuto ;
Mimura, Toshihide .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)
[4]   Phytochemicals as potential antidotes for targeting NF-κB in rheumatoid arthritis [J].
Aravilli, R. Kowshik ;
Vikram, S. Laveen ;
Kohila, V. .
3 BIOTECH, 2017, 7
[5]   Integration of the NF-κB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter:: Divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts [J].
Barchowsky, A ;
Frleta, D ;
Vincenti, MP .
CYTOKINE, 2000, 12 (10) :1469-1479
[6]   Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis [J].
Ben Mrid, Reda ;
Bouchmaa, Najat ;
Ainani, Hassan ;
El Fatimy, Rachid ;
Malka, Gabriel ;
Mazini, Loubna .
BIOMEDICINE & PHARMACOTHERAPY, 2022, 151
[7]   Novel treatment strategies in rheumatoid arthritis [J].
Burmester, Gerd R. ;
Pope, Janet E. .
LANCET, 2017, 389 (10086) :2338-2348
[8]   Matrix metalloproteinases: Role in arthritis [J].
Burrage, PS ;
Mix, KS ;
Brinckerhoff, CE .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 :529-543
[9]   Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis [J].
Chen, Zhu ;
Bozec, Aline ;
Ramming, Andreas ;
Schett, Georg .
NATURE REVIEWS RHEUMATOLOGY, 2019, 15 (01) :9-17
[10]  
Chintalacharuvu SR, 2001, J RHEUMATOL, V28, P2049